SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹234 Cr | ₹204 Cr | ₹200 Cr | ₹16,826,961 Cr | ₹167 Cr |
What is the latest Total Expenditure of SYNCOM FORMULATIONS (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹234 Cr |
| Mar2024 | ₹204 Cr |
| Mar2023 | ₹200 Cr |
| Mar2022 | ₹16,826,961 Cr |
| Mar2017 | ₹167 Cr |
How is Total Expenditure of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹234 Cr | 14.38 | |
| Mar2024 | ₹204 Cr | 2.37 | |
| Mar2023 | ₹200 Cr | -100.00 | |
| Mar2022 | ₹16,826,961 Cr | 10,062,186.55 | |
| Mar2017 | ₹167 Cr | - | |
Compare Total Expenditure of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,222.0 Cr | 15% | 8.3% | -23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | 1.3% | -4.5% | -0% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,157.0 Cr | 1.7% | -5.9% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | 2.6% | -5% | 25.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -0.4% | -7% | 3.6% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 2.6% | -7.4% | -16.3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 15% |
8.3% |
-23.3% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses